Expression of TWIST mRNA and protein in rodent glioma and human glioblastoma cell lines. (A) Northern blot analysis showing the expression of TWIST in rat C6 glioma cells (far left lane), confirming the results of a degenerate RT-PCR screen for class B bHLH genes. TWIST mRNA expression was detected in five of six human glioma cell lines (A172, T98G, SNB19, UW455, UW18, and SF767), as well as in lines derived from a neuroblastoma (SKNMC) and a medulloblastoma (D283). Lines derived from colon (SW480), breast (MDA453), and small cell lung cancer (H82) had no detectable expression. The gel stained with ethidium bromide (lower panel) demonstrates equivalent loading and integrity of total RNA. (B) Southern hybridization of TWIST-specific probes to RT-PCR products from a larger panel of human tumor cell lines. Blots of GAPDH controls show that comparable amounts of total RNA were analyzed for each sample. Differential levels of TWIST expression were detected in 11 of 12 human gliomas and in two neuoblastomas and one medulloblastoma, whereas no detectable expression was noted in non-neural tumors. TWIST mRNA was not detected by RT-PCR or by Northern blot analysis in the glioblastoma line, UW455, or in the non-neural cell lines examined. (C) Western blot analysis of 30 µg of whole cell lysates of UW455 and SF767, transfected either with an empty expression vector (LXSN) or a TWIST overexpression construct (Tw), demonstrates the presence of a band at the expected molecular mass of 26 kDa. UW455, which lacks detectable TWIST mRNA and SF767LXSN with low basal message levels, shows no detectable protein. (D) Nuclear extracts of the SF767LXSN, SNB19LXSN, and T98G cell lines (50 µg each) demonstrate endogenous expression of a 26-kDa TWIST protein comparable to that detected in nuclear extracts from SF767Tw (10 µg) at levels commensurate with mRNA levels (panel A). The nuclear protein, INI1, is used to compare the levels of nuclear-specific protein loaded from each preparation.